PROFUSA, INC. Increase (Decrease) in Accounts Payable
PROFUSA, INC. (PFSA) reported Increase (Decrease) in Accounts Payable of $510.00 thousand for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-19.
Financial Statements › Cash Flow › Operating Activities
us-gaap:IncreaseDecreaseInAccountsPayable · last filed 2026-08-19
- PROFUSA, INC. increase (decrease) in accounts payable for the quarter ending 2026-06-30 was -$454.00K, a 272.62% decline year-over-year.
- PROFUSA, INC. increase (decrease) in accounts payable for the quarter ending 2026-03-31 was $964.00K, a 26.18% increase year-over-year.
- PROFUSA, INC. increase (decrease) in accounts payable for the quarter ending 2025-12-31 was $363.00K.
- PROFUSA, INC. increase (decrease) in accounts payable for the quarter ending 2025-09-30 was $2.17M.
| Period end | Increase (Decrease) in Accounts Payable 3 month | Increase (Decrease) in Accounts Payable 6 month | Increase (Decrease) in Accounts Payable 9 month | Increase (Decrease) in Accounts Payable 12 month |
|---|---|---|---|---|
| 2026-06-30 | -$454.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-19 | $510.00K 10-Q · filed 2026-08-19 | $873.00K derived: sum of 3 quarters · filed 2026-08-19 | $3.04M derived: sum of 4 quarters · filed 2026-08-19 |
| 2026-03-31 | $964.00K 10-Q · filed 2026-05-15 | $1.33M derived: sum of 2 quarters · filed 2026-05-15 | $3.50M derived: sum of 3 quarters · filed 2026-05-15 | $3.76M derived: sum of 4 quarters · filed 2026-08-19 |
| 2025-12-31 | $363.00K derived: S-1/A 12 month − 10-Q 9 month · filed 2026-05-01 | $2.53M derived: sum of 2 quarters · filed 2026-05-01 | $2.80M derived: sum of 3 quarters · filed 2026-08-19 | $3.56M S-1/A · filed 2026-05-01 |
| 2025-09-30 | $2.17M derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-19 | $2.43M derived: sum of 2 quarters · filed 2026-08-19 | $3.20M 10-Q · filed 2025-11-19 | $3.15M derived: sum of 4 quarters · filed 2026-08-19 |
| 2025-06-30 | $263.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-19 | $1.03M 10-Q · filed 2026-08-19 | $982.00K derived: sum of 3 quarters · filed 2026-08-19 | |
| 2025-03-31 | $764.00K 10-Q · filed 2026-05-15 | $719.00K derived: sum of 2 quarters · filed 2026-05-15 | ||
| 2024-12-31 | -$45.00K derived: S-1/A 12 month − 10-Q 9 month · filed 2026-05-01 | $645.00K S-1/A · filed 2026-05-01 | ||
| 2024-09-30 | $690.00K 10-Q · filed 2025-11-19 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Tenon Medical, Inc. (TNON) | United States | $0.002B | |
| Catheter Precision, Inc. (VTAK) | United States | $0.002B | -0.23 |
| INVO Fertility, Inc. (IVF) | United States | $0.002B | -0.71 |
| NEXGEL, INC. (NXGL) | United States | $0.002B | |
| Vivos Therapeutics, Inc. (VVOS) | United States | $0.003B | -0.26 |
| Beyond Air, Inc. (XAIR) | United States | $0.003B | -0.01 |
| Autonomix Medical, Inc. (AMIX) | United States | $0.004B | |
| Adagio Medical Holdings, Inc. (ADGM) | United States | $0.004B | |
| OSR Health, Inc. (OSRH) | United States | $0.004B | -0.75 |
| Bluejay Diagnostics, Inc. (BJDX) | United States | $0.004B |